Transient lesion in the splenium of the corpus callosum: Three further cases in epileptic patients and a pathophysiological hypothesis

Journal of Neurology Neurosurgery and Psychiatry

Volumn 70, Issue 4, 2001, Pages 459-463

  Polster, T ^a,b   Hoppe, M ^a   Ebner, A ^a  

^a EPILEPSY CENTER BETHEL   (Germany)

^b Kinderzentrum Bielefeld   (Germany)

Author keywords

Anticonvulsant drugs; Argipressine; Brain oedema; Corpus callosum

Indexed keywords

ADULT; ARTICLE; BRAIN EDEMA; BRAIN TOXICITY; CASE REPORT; CORPUS CALLOSUM; EPILEPSY; EPILEPTOGENESIS; FEMALE; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; VITAMIN DEFICIENCY;

ADULT; CORPUS CALLOSUM; EPILEPSY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE;

EID: 0035064298     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.70.4.459     Document Type: Article

References (42)

1. Chason DP, Fleckenstein JL, Ginsburg MI, et al. Transient splenial edema in epilepsy: MR imaging evaluation. Proceedings of the 34th annual meeting of the American Society of Neuroradiology; June 21-27 1996, Seattle, WA, USA. Chicago: Old Smith Printers, 1996.
2. Kim SS, Chang KH, Kim ST, et al. Focal lesion in the splenium of the corpus callosum in epileptic patients: antiepileptic drug toxicity? Am J Neuroradiol 1999;20:125-9.
3. Gotman J. Seizure spread. In: Lüders H, ed. Epilepsy surgery. New York: Raven: 1991:349-54.
4. Tennison M. Focal lesion in the splenium of the corpus callosum in epileptic patients: antiepileptic drug toxicity? [commentary]. Am J Neuroradiol 1999;20:131-2.
5. Kramer RE, Lüders H, Lesser RP, et al. Transient focal abnormalities of neuroimaging studies during focal status epilepticus. Epilepsia 1987;28:528-32.
6. Henry TR, Drury I, Brunberg JA, et al. Focal cerebral magnetic resonance changes asociated with partial status epilepticus. Epilepsia 1994;35:35-11.
7. Tuxhorn I, Holthausen H, Ebner A, et al. Reversible cortical oedema mimicking cortical dysplasia in mitochondrial disorder. J Neurol Neurosurg Psychiatry 1994;57:1439.
8. Yaffe K, Ferriero D, Barkovich AJ, et al. Reversible MRI abnormalities following seizures. Neurology 1995;45:104-8.
9. Silverstein AM, Alexander JA. Acute postictal cerbral imaging. Am J Neuroradiol 1998;19:1485-8.
10. Hauser RA, Lacey DM, Knight MR. Hypertensive encephalopathy.Arch Neurol 1988;45:1078-83.
11. Ito T, Sakai T, Inagawa S, et al. MR angiography of cerebral vasospasm in preeclampsia. Am J Neuroradiol 1995;16: 1344-6.
12. Cordoliani YS, Sarrazin JL, Felten D, et al. MR of cerebral malaria. Am J Neuroradiol 1998;19:871-4.
13. Tokutomi T, Hirohata M, Miyagi T, et al. Posttraumatic edema in the corpus callosum shown by MRI. Acta Neurochir (Wien) 1997;70(suppl):80-3.
14. Cecil KM, Hills EC, Sandel ME, et al. Proton magnetic resonance spectroscopy for detection of axonal injury in the splenium of the corpus callosum of brain-injured patients. J Neurosurg 1998;88:795-801.
15. Mendelsohn DB, Levin HS, Harward H, et al. Corpus callosum lesions after closed head injury in children: MRI, clinical features and outcome. Neuroradiology 1992;34:384-8.
16. Ogura H, Takaoka M, Kishi M, et al. Reversible MR findings of hemolytic uremic syndrome with mild encephalopathy. Am J Neuroradiol 1998;19:1144-5.
17. Hackett PH, Yarnell PR, Hill R, et al. High-altitude cerebral edema evaluated with magnetic resonance imaging. JAMA 1998;280:1920-5.
18. Klatzko I. Pathophysiological aspects of brain edema. Acta Neuropathol 1987;72:236-9.
19. Moody DM, Bell MA, Challa VR. The corpus callosum, a unique white-matter tract: anatomic features that may explain sparing in Binswanger disease and resistance to flow of fluid masses. Am J Neuroradiol 1988;9:1051-9.
20. Moody DM, Bell MA, Challa VR. Features of the cerebral vascular pattern that predict vulnerability to perfusion or oxygenation deficiency: an anatomic study. Am J Neuroradiol 1990;11:431-9.
21. Tsugane S, Suzuki Y, Takayasu M, et al. Effects of vasopressin on regional cerebral blood flow in dogs. J Auton Nerv Sys 1994;49:S133-6.
22. Doczi T, Szerdahelyi P, Gulya K, et al. Brain water accumulation after central administration of vasopressin. Neurosurgery 1982;11:402-7.
23. Raichle ME, Grubb RL. Regulation of brain water permeability by centrally-released vasopressin. Brain Res 1978;143:191-4.
24. Krause KH, Rascher W, Berlit P. Plasma arginine vasopressin concentrations in epileptics under monotherapy. J Neurol 1983;230:193-6.
25. Stephens WP, Coe JY, Baylis PH. Plasma arginine vasopressin concentrations and antidiuretic action of carbamazepine. BMJ 1978;i:1445-7.
26. Soelberg Sørensen P, Hammer M. Effects of long-term carbamazepine treatment on water metabolism and plasma vasopressin concentration. Eur J Clin Pharmacol 1984;26: 719-22.
27. Sordillo P, Sagransky DM, Mercado R, et al. Carbamazepine-induced syndrome of inappropriate antidiuretic hormone secretion. Arch Intern Med 1978;138: 299-301.
28. Fichman MP, Kleeman CP, Bethune JE. Inhibition of antidiuretic hormone secretion by diphenylhydantoin. Arch Neurol 1970;22:45-53.
29. Padilla G, Leake JA, Castro R, et al. Vasopressin levels and pediatric head trauma. Pediatrics 1989;83:700-5.
30. Born JD, Hans P, Smitz S, et al. Syndrome of inappropriate secretion of antidiuretic hormone after severe head injury. Surg Neurol 1985;23:383-7.
31. Doczi T, Tarjanyi J, Huzska E, et al. Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) after head injury. Neurosurgery 1982;10;685-8.
32. Aboitiz F, Scheibel AB, Fisher RS, et al. Fiber composition of the human corpus callosum. Brain Res 1992;558:143-53.
33. Highley JR, Esiri MM, McDonald B, et al. The size and fibre composition of the corpus callosum with respect to gender and schizophrenia: a post-mortem study. Brain 1999;122: 99-110.
34. Lamantia AS, Rakic P. Cytological and quantitative characteristics of four cerebral commissures in the rhesus monkey. J Comp Neurol 1990;291:520-37.
35. Kakou M, Velut S, Destrieux C. Vascularisation artérielle et veineuse du corps calleux. Neurochirurgie 1998;4(suppl 1):31-7.
36. Ferracci F, Conte F, Gentile M, et al. Marchiafava-Bignami disease. Arch Neurol 1999;56:107-10.
37. Gabriel S, Großmann A, Höppner J, et al. Marchiafava-Bignami-Syndrom. Nervenarzt 1999;70:349-56.
38. Heepe P, Nemeth L, Brune F, et al. Marchiafava-Bignami disease. European Archives of Psychiatry and Neurolscience 1988;237:74-9.
39. Ghatak NR, Hadfield MG, Rosenblum WI. Association of central pontine myelinolysis and Marchiafava-Bignami disease. Neurology 1978;28:1295-8.
40. Strohmaier A, Fink GA, Hüppe T, et al. Verlauf einer zentralen pontinen Myelinolyse mit klinischer Erholung. Radiologe 1995;35:294-6.
41. Sterns RH, Riggs JE, Schochet SS. Osmotic demyelination syndrome following correction of hyponatremia. N Engl J Med 1986;314:1535-12.
42. Ramaekers VT, Reul J, Kusenbach G, et al. Central pontine myelinolysis associated with acquired folate depletion. Neuropediatrics 1997;28:126-30.